Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) Return on Invested Capital (2022 - 2025)

Q32 Bio (QTTB) has 4 years of Return on Invested Capital data on record, last reported at 20.44% in Q2 2025.

  • For Q2 2025, Return on Invested Capital rose 2184.0% year-over-year to 20.44%; the TTM value through Jun 2025 reached 20.44%, up 2184.0%, while the annual FY2024 figure was 0.76%, 45.0% up from the prior year.
  • Return on Invested Capital reached 20.44% in Q2 2025 per QTTB's latest filing, up from 13.48% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 20.44% in Q2 2025 and bottomed at 13.48% in Q1 2025.
  • Average Return on Invested Capital over 4 years is 0.77%, with a median of 0.99% recorded in 2022.
  • The widest YoY moves for Return on Invested Capital: up 2184bps in 2025, down -1432bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 6.11% in 2022, then surged by 104bps to 0.27% in 2023, then plummeted by -1835bps to 4.62% in 2024, then skyrocketed by 542bps to 20.44% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 20.44% in Q2 2025, 13.48% in Q1 2025, and 4.62% in Q4 2024.